These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25200885)

  • 1. [Acute psychosis as a side effect of efavirenz therapy with metabolic anomalies: an important differential diagnosis of HIV-associated psychoses].
    Hinsch MC; Reichelt D; Husstedt IW
    Nervenarzt; 2014 Oct; 85(10):1304-8. PubMed ID: 25200885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat episode of late-onset psychosis associated with efavirenz.
    Basterreche N; Arrúe A; Arnaiz A; Olivas O; Zumárraga M
    Actas Esp Psiquiatr; 2020 Jul; 48(4):181-90. PubMed ID: 32920783
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV and mental illness in Malawi and the neuropsychiatric sequelae of efavirenz.
    Drury A; Gleadow-Ware S; Gilfillan S; Ahrens J
    Malawi Med J; 2018 Mar; 30(1):40-45. PubMed ID: 29868159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.
    Mukonzo JK; Okwera A; Nakasujja N; Luzze H; Sebuwufu D; Ogwal-Okeng J; Waako P; Gustafsson LL; Aklillu E
    BMC Infect Dis; 2013 Jun; 13():261. PubMed ID: 23734829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Discontinuation of Efavirenz as Treatment for HIV, Due to Neuropsychiatric Side Effects, in a Multi-Ethnic Sample in the United Kingdom.
    Law JKC; Butler LT; Hamill MM
    AIDS Res Hum Retroviruses; 2020 Jun; 36(6):459-466. PubMed ID: 31931589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of dizziness in human immunodeficiency virus-infected patients taking zidovudine and efavirenz combination: a Brazilian cohort study.
    Valeriano JJLS; Carvalho-Silva WHV; Coelho AVC; Moura RR; Arraes LC; Brandão LAC; Crovella S; Guimarães RL
    J Pharm Pharmacol; 2020 May; 72(5):719-727. PubMed ID: 32043598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of efavirenz for neuropsychiatry: a review.
    Cavalcante GI; Capistrano VL; Cavalcante FS; Vasconcelos SM; Macêdo DS; Sousa FC; Woods DJ; Fonteles MM
    Int J Neurosci; 2010 Dec; 120(12):739-45. PubMed ID: 20964556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe psychosis in an African woman due to the antiretroviral agent efavirenz].
    van Twillert G; van Santen G; Godfried MH
    Ned Tijdschr Geneeskd; 2005 Nov; 149(48):2687-9. PubMed ID: 16358620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications.
    Gaida R; Truter I; Grobler C; Kotze T; Godman B
    Expert Rev Anti Infect Ther; 2016; 14(4):377-88. PubMed ID: 26900637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efavirenz intoxication due to slow hepatic metabolism.
    Hasse B; Günthard HF; Bleiber G; Krause M
    Clin Infect Dis; 2005 Feb; 40(3):e22-3. PubMed ID: 15668854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies.
    Chang JL; Lee SA; Tsai AC; Musinguzi N; Muzoora C; Bwana B; Boum Y; Haberer JE; Hunt PW; Martin J; Bangsberg DR; Kroetz DL; Siedner MJ
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):982-992. PubMed ID: 29973058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the associations of CYP2B6-516G>T polymorphisms with efavirenz-induced central nervous system side effects and virological outcome in HIV-infected adults.
    Cheng L; Wang Y; Li X; Feng W; Weng B; Yuan Q; Xia P; Sun F
    Pharmacogenomics J; 2020 Apr; 20(2):246-259. PubMed ID: 31636355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychiatric diseases and HIV infection. These patients are dually stigmatized].
    Arendt G; Haslinger BA
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():70-2. PubMed ID: 15011597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.
    Wyen C; Hendra H; Siccardi M; Platten M; Jaeger H; Harrer T; Esser S; Bogner JR; Brockmeyer NH; Bieniek B; Rockstroh J; Hoffmann C; Stoehr A; Michalik C; Dlugay V; Jetter A; Knechten H; Klinker H; Skaletz-Rorowski A; Fätkenheuer G; Egan D; Back DJ; Owen A;
    J Antimicrob Chemother; 2011 Sep; 66(9):2092-8. PubMed ID: 21715435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report.
    van Ramshorst MS; Kekana M; Struthers HE; McIntyre JA; Peters RP
    BMC Pediatr; 2013 Aug; 13():120. PubMed ID: 23941256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
    João EC; Morrison RL; Shapiro DE; Chakhtoura N; Gouvèa MIS; de Lourdes B Teixeira M; Fuller TL; Mmbaga BT; Ngocho JS; Njau BN; Violari A; Mathiba R; Essack Z; Pilotto JHS; Moreira LF; Rolon MJ; Cahn P; Prommas S; Cressey TR; Chokephaibulkit K; Werarak P; Laimon L; Hennessy R; Frenkel LM; Anthony P; Best BM; Siberry GK; Mirochnick M
    Lancet HIV; 2020 May; 7(5):e322-e331. PubMed ID: 32386720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?
    Wynberg E; Williams E; Tudor-Williams G; Lyall H; Foster C
    Clin Drug Investig; 2018 Mar; 38(3):231-238. PubMed ID: 29181714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India.
    Ramachandran G; Hemanth Kumar AK; Rajasekaran S; Kumar P; Ramesh K; Anitha S; Narendran G; Menon P; Gomathi C; Swaminathan S
    Antimicrob Agents Chemother; 2009 Mar; 53(3):863-8. PubMed ID: 19124658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe psychosis in an African woman due to the antiretroviral agent efavirenz].
    Sierink HD; Bloemkolk D
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):642-3; author reply 644. PubMed ID: 16610509
    [No Abstract]   [Full Text] [Related]  

  • 20. Efavirenz and the CNS: what we already know and questions that need to be answered.
    Apostolova N; Funes HA; Blas-Garcia A; Galindo MJ; Alvarez A; Esplugues JV
    J Antimicrob Chemother; 2015 Oct; 70(10):2693-708. PubMed ID: 26203180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.